1.
Bark SKN, Ahmad R, Dantzler K, et al. Quantitative Proteomic Profiling Reveals Novel Surface Antigens and Possible Vaccine Candidates. Mol Cell Proteomics. 2018;17(1):43-60. doi:10.1074/mcp.RA117.000076.
1.
Early AM, Lievens M, MacInnis BL, et al. Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections. Nat Commun. 2018;9(1):1381. doi:10.1038/s41467-018-03807-7.
1.
Martyn DC, Ramirez AP, Beattie MJ, et al. Synthesis of spiro-1,2-dioxolanes and their activity against Plasmodium falciparum. Bioorg Med Chem Lett. 2008;18(24):6521-4. doi:10.1016/j.bmcl.2008.10.083.
1.
Deme AB, Park DJ, Bei AK, et al. Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests. Malar J. 2014;13:34. doi:10.1186/1475-2875-13-34.
1.
Bei AK, Diouf A, Miura K, et al. Immune characterization of Plasmodium falciparum parasites with a shared genetic signature in a region of decreasing transmission. Infect Immun. 2015;83(1):276-85. doi:10.1128/IAI.01979-14.
1.
Torres KJ, Castrillon CE, Moss EL, et al. Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon. J Infect Dis. 2015;211(8):1342-51. doi:10.1093/infdis/jiu614.
1.
Chuquiyauri R, Molina DM, Moss EL, et al. Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg. 2015;93(4):801-9. doi:10.4269/ajtmh.15-0232.
1.
Gunalan K, Lo E, Hostetler JB, et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Natl Acad Sci U S A. 2016;113(22):6271-6. doi:10.1073/pnas.1606113113.